IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s f...
In a weak quarter for brokerages, RXO’s stock price takes a pounding after earnings
(A quick summary of some key points of RXO’s earnings can be found here. ) With four publicly-traded freight brokerages now having reported earnings for the fourth qua...
Under Armour (NYSE:UAA) Delivers Impressive Q4, Stock Soars
Athletic apparel company Under Armour (NYSE:UAA) reported Q4 CY2024 results beating Wall Street’s revenue expectations , but sales fell by 5.7% year on year to $1.40 billion. Its non...
